Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge por Gerald K. Chege, Rosamund E. Chapman, Alana T. Keyser, Craig H. Adams, Kealan Benn, Michiel T. van Diepen, Nicola Douglass, Bronwen Lambson, Tandile Hermanus, Penny L. Moore, Anna-Lise Williamson

Obter o texto integral